Early and complete vitrectomy versus tap and inject in acute post cataract surgery endophthalmitis presenting with hand motion vision; a quasi-experimental study.
Cataract surgery
EVS
Endophthalmitis
Endophthalmitis vitrectomy study
Vitrectomy
Journal
BMC ophthalmology
ISSN: 1471-2415
Titre abrégé: BMC Ophthalmol
Pays: England
ID NLM: 100967802
Informations de publication
Date de publication:
08 Jan 2022
08 Jan 2022
Historique:
received:
12
08
2021
accepted:
04
01
2022
entrez:
9
1
2022
pubmed:
10
1
2022
medline:
12
1
2022
Statut:
epublish
Résumé
Based on endophthalmitis vitrectomy study, intravitreal injection of antibiotics is preferred for initial management of cases of acute post cataract surgery endophthalmitis (APCE) with presenting vision of hand motions (HM). This study aimed to compare outcomes of early and complete vitrectomy (VIT) and vitreous tap and antibiotic injection (T&I) in cases of APCE presented with vision of HM. In this prospective study, cases of APCE with vision of HM between 2018 and 2020 were enrolled. According to the time of presentation, the patients were arranged into two groups (VIT vs. T&I). Demographic data, elapsed time to developing endophthalmitis, past medical history, microbiology results, complications, and final visual acuity were recorded and analyzed. Seventy-six eyes of 76 patients were enrolled. Fifty-three eyes underwent T&I and twenty-three were arranged into the VIT group. Past medical history of 34.2% of patients was significant for diabetes mellitus. There was a statistically significant lower logMAR in VIT group compared to T&I group (diff = 0.14, 95% CI: 0.04 to 0.24, P-value = 0.007). The comparison of the diabetic and non-diabetic patients in both groups showed that the visual outcome was better in non-diabetic cases compared to the diabetic subjects. There was no statistically significant difference between the diabetic and non-diabetic groups regarding the superiority of procedure. Based on our results, we could recommend that it's maybe better to do early and complete vitrectomy as the initial management of APCE with the vision of HM. Past medical history of diabetes mellitus is not a determining factor for choosing initial management between vitrectomy and antibiotic injection.
Sections du résumé
BACKGROUND
BACKGROUND
Based on endophthalmitis vitrectomy study, intravitreal injection of antibiotics is preferred for initial management of cases of acute post cataract surgery endophthalmitis (APCE) with presenting vision of hand motions (HM). This study aimed to compare outcomes of early and complete vitrectomy (VIT) and vitreous tap and antibiotic injection (T&I) in cases of APCE presented with vision of HM.
METHODS
METHODS
In this prospective study, cases of APCE with vision of HM between 2018 and 2020 were enrolled. According to the time of presentation, the patients were arranged into two groups (VIT vs. T&I). Demographic data, elapsed time to developing endophthalmitis, past medical history, microbiology results, complications, and final visual acuity were recorded and analyzed.
RESULTS
RESULTS
Seventy-six eyes of 76 patients were enrolled. Fifty-three eyes underwent T&I and twenty-three were arranged into the VIT group. Past medical history of 34.2% of patients was significant for diabetes mellitus. There was a statistically significant lower logMAR in VIT group compared to T&I group (diff = 0.14, 95% CI: 0.04 to 0.24, P-value = 0.007). The comparison of the diabetic and non-diabetic patients in both groups showed that the visual outcome was better in non-diabetic cases compared to the diabetic subjects. There was no statistically significant difference between the diabetic and non-diabetic groups regarding the superiority of procedure.
CONCLUSION
CONCLUSIONS
Based on our results, we could recommend that it's maybe better to do early and complete vitrectomy as the initial management of APCE with the vision of HM. Past medical history of diabetes mellitus is not a determining factor for choosing initial management between vitrectomy and antibiotic injection.
Identifiants
pubmed: 34998363
doi: 10.1186/s12886-022-02247-8
pii: 10.1186/s12886-022-02247-8
pmc: PMC8742950
doi:
Substances chimiques
Anti-Bacterial Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
16Informations de copyright
© 2022. The Author(s).
Références
Clin Microbiol Infect. 2013 Mar;19(3):227-34
pubmed: 23438028
Surv Ophthalmol. 2018 Sep - Oct;63(5):677-693
pubmed: 29453989
Cornea. 1990 Apr;9(2):102-7
pubmed: 2109672
Ocul Immunol Inflamm. 2021 Jul 4;29(5):871-876
pubmed: 31906757
Am J Ophthalmol. 1996 Dec;122(6):830-46
pubmed: 8956638
Oftalmologia. 2006;50(3):65-8
pubmed: 17144510
Arch Ophthalmol. 1992 Oct;110(10):1450-4
pubmed: 1417545
Ophthalmology. 2005 Aug;112(8):1388-94
pubmed: 15953637
Eye (Lond). 1998;12 ( Pt 6):910-5
pubmed: 10325984
Arch Ophthalmol. 1991 Apr;109(4):487-9
pubmed: 2012545
Arch Ophthalmol. 2005 May;123(5):613-20
pubmed: 15883279
Am J Ophthalmol. 2016 May;165:16-22
pubmed: 26921804
Clin Ophthalmol. 2020 Jul 08;14:1945-1954
pubmed: 32753837
Eur J Clin Microbiol Infect Dis. 2012 Nov;31(11):2879-86
pubmed: 22664925
Arch Ophthalmol. 2006 Apr;124(4):479-83
pubmed: 16606872
Arch Ophthalmol. 1995 Dec;113(12):1479-96
pubmed: 7487614
Am J Ophthalmol. 1996 Jul;122(1):1-17
pubmed: 8659579
Ocul Immunol Inflamm. 2020 Oct 15;:1-7
pubmed: 33054484
Acta Ophthalmol. 2018 Aug;96(5):e651-e654
pubmed: 29197165
J Biotechnol. 2014 Dec 10;191:121-30
pubmed: 25240440
Graefes Arch Clin Exp Ophthalmol. 2005 Dec;243(12):1197-9
pubmed: 16136321
Retina. 2007 Jul-Aug;27(6):662-80
pubmed: 17621174
Eye (Lond). 2008 Oct;22(10):1290-300
pubmed: 18356929
Ophthalmology. 2014 Aug;121(8):1634-42
pubmed: 24702755